Insulin resistance in the defense against obesity

Cell Metabolism

Volumn 15, Issue 6, 2012, Pages 798-804

  Saltiel, Alan R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; LEPTIN;

DESENSITIZATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INSULIN RESISTANCE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW;

ANIMALS; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; LEPTIN; OBESITY;

EID: 84862001089     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2012.03.001     Document Type: Review

References (101)

1. Aguirre, V., Werner, E.D., Giraud, J., Lee, Y.H., Shoelson, S.E., and White, M.F. (2002). Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 277, 1531-1537. (Pubitemid 34968910)
2. Allen, T.L., and Febbraio, M.A. (2010). IL6 as a mediator of insulin resistance: fat or fiction? Diabetologia 53, 399-402.
3. Arkan, M.C., Hevener, A.L., Greten, F.R., Maeda, S., Li, Z.W., Long, J.M., Wynshaw-Boris, A., Poli, G., Olefsky, J., and Karin, M. (2005). IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 11, 191-198. (Pubitemid 40321355)
4. Aron-Wisnewsky, J., Tordjman, J., Poitou, C., Darakhshan, F., Hugol, D., Basdevant, A., Aissat, A., Guerre-Millo, M., and Clément, K. (2009). Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J. Clin. Endocrinol. Metab. 94, 4619-4623.
5. Badman, M.K., and Flier, J.S. (2007). The adipocyte as an active participant in energy balance and metabolism. Gastroenterology 132, 2103-2115. (Pubitemid 46693755)
6. Bar, R.S., Harrison, L.C., Muggeo, M., Gorden, P., Kahn, C.R., and Roth, J. (1979). Regulation of insulin receptors in normal and abnormal physiology in humans. Adv. Intern. Med. 24, 23-52.
7. Biddinger, S.B., and Kahn, C.R. (2006). From mice to men: insights into the insulin resistance syndromes. Annu. Rev. Physiol. 68, 123-158.
8. Blackburn, P., Després, J.P., Lamarche, B., Tremblay, A., Bergeron, J., Lemieux, I., and Couillard, C. (2006). Postprandial variations of plasma inflammatory markers in abdominally obese men. Obesity (Silver Spring) 14, 1747-1754. (Pubitemid 46214797)
9. Bogardus, C., Lillioja, S., Mott, D.M., Hollenbeck, C., and Reaven, G. (1985). Relationship between degree of obesity and in vivo insulin action in man. Am. J. Physiol. 248, E286-E291. (Pubitemid 15076590)
10. Carpentier, J.L., Fehlmann, M., Van Obberghen, E., Gorden, P., and Orci, L. (1985). Insulin receptor internalization and recycling: mechanism and significance. Biochimie 67, 1143-1145. (Pubitemid 16195738)
11. Chiang, S.H., Bazuine, M., Lumeng, C.N., Geletka, L.M., Mowers, J., White, N.M., Ma, J.T., Zhou, J., Qi, N., Westcott, D., et al. (2009). The protein kinase IKKepsilon regulates energy balance in obese mice. Cell 138, 961-975.
12. Chun, T.H., Hotary, K.B., Sabeh, F., Saltiel, A.R., Allen, E.D., and Weiss, S.J. (2006). A pericellular collagenase directs the 3-dimensional development of white adipose tissue. Cell 125, 577-591.
13. Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A.S., and Obin, M.S. (2005). Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 46, 2347-2355. (Pubitemid 41532523)
14. Clark, K., Peggie, M., Plater, L., Sorcek, R.J., Young, E.R., Madwed, J.B., Hough, J., McIver, E.G., and Cohen, P. (2011). Novel cross-talk within the IKK family controls innate immunity. Biochem. J. 434, 93-104.
15. Collins, S., Kuhn, C.M., Petro, A.E., Swick, A.G., Chrunyk, B.A., and Surwit, R.S. (1996). Role of leptin in fat regulation. Nature 380, 677. (Pubitemid 26126093)
16. Delhase, M., Hayakawa, M., Chen, Y., and Karin, M. (1999). Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284, 309-313. (Pubitemid 129523447)
17. Doria, A., Patti, M.E., and Kahn, C.R. (2008). The emerging genetic architecture of type 2 diabetes. Cell Metab. 8, 186-200.
18. Dunne, A., and O'Neill, L.A. (2003). The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE 2003, re3.
19. Farooqi, I.S., Bullmore, E., Keogh, J., Gillard, J., O'Rahilly, S., and Fletcher, P.C. (2007). Leptin regulates striatal regions and human eating behavior. Science 317, 1355. (Pubitemid 47417470)
20. Festa, A., D'Agostino, R., Jr., Tracy, R.P., and Haffner, S.M.; Insulin Resistance Atherosclerosis Study. (2002). Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51, 1131-1137. (Pubitemid 34438360)
21. Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A.B., Benoist, C., Shoelson, S., and Mathis, D. (2009). Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15, 930-939.
22. Friedman, J.M. (2004). Modern science versus the stigma of obesity. Nat. Med. 10, 563-569.
23. Friedman, J.M., and Halaas, J.L. (1998). Leptin and the regulation of body weight in mammals. Nature 395, 763-770. (Pubitemid 28485436)
24. Goldfine, A.B., Fonseca, V., Jablonski, K.A., Pyle, L., Staten, M.A., and Shoelson, S.E.; TINSAL-T2D (Targeting Inflammation Using Salsalate in Type 2 Diabetes) Study Team. (2010). The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann. Intern. Med. 152, 346-357.
25. Gregor, M.F., and Hotamisligil, G.S. (2011). Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29, 415-445.
26. Grujic, D., Susulic, V.S., Harper, M.E., Himms-Hagen, J., Cunningham, B.A., Corkey, B.E., and Lowell, B.B. (1997). Beta3-adrenergic receptors on white and brown adipocytes mediate beta3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. A study using transgenic and gene knockout mice. J. Biol. Chem. 272, 17686-17693. (Pubitemid 27311206)
27. Halaas, J.L., Gajiwala, K.S., Maffei, M., Cohen, S.L., Chait, B.T., Rabinowitz, D., Lallone, R.L., Burley, S.K., and Friedman, J.M. (1995). Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269, 543-546.
28. Halaas, J.L., Boozer, C., Blair-West, J., Fidahusein, N., Denton, D.A., and Friedman, J.M. (1997). Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc. Natl. Acad. Sci. USA 94, 8878-8883. (Pubitemid 27335133)
29. Hardie, D.G. (2003). Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 144, 5179-5183.
30. Hirosumi, J., Tuncman, G., Chang, L., Görgün, C.Z., Uysal, K.T., Maeda, K., Karin, M., and Hotamisligil, G.S. (2002). A central role for JNK in obesity and insulin resistance. Nature 420, 333-336. (Pubitemid 35398190)
31. Holland, W.L., Brozinick, J.T., Wang, L.P., Hawkins, E.D., Sargent, K.M., Liu, Y., Narra, K., Hoehn, K.L., Knotts, T.A., Siesky, A., et al. (2007). Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesityinduced insulin resistance. Cell Metab. 5, 167-179.
32. Hosogai, N., Fukuhara, A., Oshima, K., Miyata, Y., Tanaka, S., Segawa, K., Furukawa, S., Tochino, Y., Komuro, R., Matsuda, M., and Shimomura, I. (2007). Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56, 901-911. (Pubitemid 46525054)
33. Hotamisligil, G.S. (2010). Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140, 900-917.
34. Hotamisligil, G.S., Peraldi, P., Budavari, A., Ellis, R., White, M.F., and Spiegelman, B.M. (1996). IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271, 665-668. (Pubitemid 26052915)
35. Hundal, R.S., Petersen, K.F., Mayerson, A.B., Randhawa, P.S., Inzucchi, S., Shoelson, S.E., and Shulman, G.I. (2002). Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J. Clin. Invest. 109, 1321-1326. (Pubitemid 34546896)
36. Itani, S.I., Ruderman, N.B., Schmieder, F., and Boden, G. (2002). Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51, 2005-2011. (Pubitemid 34729001)
37. Kahn, B.B., Alquier, T., Carling, D., and Hardie, D.G. (2005). AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1, 15-25. (Pubitemid 43960587)
38. Kawai, T., and Akira, S. (2007). Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med. 13, 460-469.
39. Khan, T., Muise, E.S., Iyengar, P., Wang, Z.V., Chandalia, M., Abate, N., Zhang, B.B., Bonaldo, P., Chua, S., and Scherer, P.E. (2009). Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol. Cell. Biol. 29, 1575-1591.
40. Kim, J.K., Fillmore, J.J., Sunshine, M.J., Albrecht, B., Higashimori, T., Kim, D.W., Liu, Z.X., Soos, T.J., Cline, G.W., O'Brien, W.R., et al. (2004). PKC-theta knockout mice are protected from fat-induced insulin resistance. J. Clin. Invest. 114, 823-827. (Pubitemid 39578741)
41. Kim, J.Y., van de Wall, E., Laplante, M., Azzara, A., Trujillo, M.E., Hofmann, S.M., Schraw, T., Durand, J.L., Li, H., Li, G., et al. (2007). Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 117, 2621-2637. (Pubitemid 47494363)
42. Kosteli, A., Sugaru, E., Haemmerle, G., Martin, J.F., Lei, J., Zechner, R., and Ferrante, A.W., Jr. (2010). Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J. Clin. Invest. 120, 3466-3479.
43. Kravchenko, V.V., Mathison, J.C., Schwamborn, K., Mercurio, F., and Ulevitch, R.J. (2003). IKKi/IKKepsilon plays a key role in integrating signals induced by pro-inflammatory stimuli. J. Biol. Chem. 278, 26612-26619. (Pubitemid 36876806)
44. Lazar, D.F., and Saltiel, A.R. (2006). Lipid phosphatases as drug discovery targets for type 2 diabetes. Nat. Rev. Drug Discov. 5, 333-342.
45. Lee, Y.S., Li, P., Huh, J.Y., Hwang, I.J., Lu, M., Kim, J.I., Ham, M., Talukdar, S., Chen, A., Lu, W.J., et al. (2011). Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes 60, 2474-2483.
46. Lesniewski, L.A., Hosch, S.E., Neels, J.G., de Luca, C., Pashmforoush, M., Lumeng, C.N., Chiang, S.H., Scadeng, M., Saltiel, A.R., and Olefsky, J.M. (2007). Bone marrow-specific Cap gene deletion protects against high-fat dietinduced insulin resistance. Nat. Med. 13, 455-462. (Pubitemid 46559827)
47. Li, S., Brown, M.S., and Goldstein, J.L. (2010a). Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc. Natl. Acad. Sci. USA 107, 3441-3446.
48. Li, P., Lu, M., Nguyen, M.T., Bae, E.J., Chapman, J., Feng, D., Hawkins, M., Pessin, J.E., Sears, D.D., Nguyen, A.K., et al. (2010b). Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice. J. Biol. Chem. 285, 15333-15345.
49. Li, P., Fan, W., Xu, J., Lu, M., Yamamoto, H., Auwerx, J., Sears, D.D., Talukdar, S., Oh, D., Chen, A., et al. (2011). Adipocyte NCoR knockout decreases PPARg phosphorylation and enhances PPARg activity and insulin sensitivity. Cell 147, 815-826.
50. Lu, M., Sarruf, D.A., Talukdar, S., Sharma, S., Li, P., Bandyopadhyay, G., Nalbandian, S., Fan, W., Gayen, J.R., Mahata, S.K., et al. (2011). Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones. Nat. Med. 17, 618-622.
51. Lumeng, C.N., and Saltiel, A.R. (2011). Inflammatory links between obesity and metabolic disease. J. Clin. Invest. 121, 2111-2117.
52. Lumeng, C.N., Bodzin, J.L., and Saltiel, A.R. (2007a). Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184. (Pubitemid 46048464)
53. Lumeng, C.N., Deyoung, S.M., and Saltiel, A.R. (2007b). Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am. J. Physiol. Endocrinol. Metab. 292, E166-E174. (Pubitemid 46052939)
54. Minokoshi, Y., Kim, Y.B., Peroni, O.D., Fryer, L.G., Müller, C., Carling, D., and Kahn, B.B. (2002). Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339-343. (Pubitemid 34087557)
55. Myers, M.G., Jr., Leibel, R.L., Seeley, R.J., and Schwartz, M.W. (2010). Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol. Metab. 21, 643-651.
56. Nakamura, T., Furuhashi, M., Li, P., Cao, H., Tuncman, G., Sonenberg, N., Gorgun, C.Z., and Hotamisligil, G.S. (2010). Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell 140, 338-348.
57. Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M., Otsu, M., Hara, K., Ueki, K., Sugiura, S., et al. (2009). CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 15, 914-920.
58. Odegaard, J.I., and Chawla, A. (2011). Alternative macrophage activation and metabolism. Annu. Rev. Pathol. 6, 275-297.
59. Oh, D.Y., Talukdar, S., Bae, E.J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W.J., Watkins, S.M., and Olefsky, J.M. (2010). GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687-698.
60. Olefsky, J.M., and Glass, C.K. (2010). Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72, 219-246.
61. Oral, E.A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P., Wagner, A.J., DePaoli, A.M., Reitman, M.L., Taylor, S.I., et al. (2002). Leptin-replacement therapy for lipodystrophy. N. Engl. J. Med. 346, 570-578. (Pubitemid 34438818)
62. Ortega Martinez de Victoria, E., Xu, X., Koska, J., Francisco, A.M., Scalise, M., Ferrante, A.W., Jr., and Krakoff, J. (2009). Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy Pima Indians. Diabetes 58, 385-393.
63. Pasarica, M., Gowronska-Kozak, B., Burk, D., Remedios, I., Hymel, D., Gimble, J., Ravussin, E., Bray, G.A., and Smith, S.R. (2009). Adipose tissue collagen VI in obesity. J. Clin. Endocrinol. Metab. 94, 5155-5162.
64. Patsouris, D., Neels, J.G., Fan, W., Li, P.P., Nguyen, M.T., and Olefsky, J.M. (2009). Glucocorticoids and thiazolidinediones interfere with adipocyte-mediated macrophage chemotaxis and recruitment. J. Biol. Chem. 284, 31223-31235.
65. Pelleymounter, M.A., Cullen, M.J., Baker, M.B., Hecht, R., Winters, D., Boone, T., and Collins, F. (1995). Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269, 540-543.
66. Polak, P., Cybulski, N., Feige, J.N., Auwerx, J., Rüegg, M.A., and Hall, M.N. (2008). Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab. 8, 399-410.
67. Pradhan, A.D., Manson, J.E., Rifai, N., Buring, J.E., and Ridker, P.M. (2001). C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286, 327-334. (Pubitemid 32656163)
68. Reaven, G.M. (2005a). The insulin resistance syndrome: definition and dietary approaches to treatment. Annu. Rev. Nutr. 25, 391-406.
69. Reaven, G.M. (2005b). Why Syndrome X? From Harold Himsworth to the insulin resistance syndrome. Cell Metab. 1, 9-14.
70. Rosenbaum, M., and Leibel, R.L. (2010). Adaptive thermogenesis in humans. Int J Obes (Lond) 34 (Suppl 1), S47-S55.
71. Saberi, M., Woods, N.B., de Luca, C., Schenk, S., Lu, J.C., Bandyopadhyay, G., Verma, I.M., and Olefsky, J.M. (2009). Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab. 10, 419-429.
72. Saltiel, A.R. (2001). New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104, 517-529.
73. Saltiel, A.R., and Kahn, C.R. (2001). Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799-806. (Pubitemid 34000783)
74. Samuel, V.T., Petersen, K.F., and Shulman, G.I. (2010). Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375, 2267-2277.
75. Savage, D.B., Petersen, K.F., and Shulman, G.I. (2007). Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev. 87, 507-520. (Pubitemid 47084679)
76. Schenk, S., Saberi, M., and Olefsky, J.M. (2008). Insulin sensitivity: modulation by nutrients and inflammation. J. Clin. Invest. 118, 2992-3002.
77. Seals, D.R., and Bell, C. (2004). Chronic sympathetic activation: consequence and cause of age-associated obesity? Diabetes 53, 276-284. (Pubitemid 38174541)
78. Shi, H., Kokoeva, M.V., Inouye, K., Tzameli, I., Yin, H., and Flier, J.S. (2006). TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015-3025. (Pubitemid 44684486)
79. Souza, S.C., Palmer, H.J., Kang, Y.H., Yamamoto, M.T., Muliro, K.V., Paulson, K.E., and Greenberg, A.S. (2003). TNF-alpha induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes. J. Cell. Biochem. 89, 1077-1086. (Pubitemid 36959377)
80. Spencer, M., Unal, R., Zhu, B., Rasouli, N., McGehee, R.E., Jr., Peterson, C.A., and Kern, P.A. (2011). Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance. J. Clin. Endocrinol. Metab. 96, 1990-1998.
81. Spiegelman, B.M., and Flier, J.S. (2001). Obesity and the regulation of energy balance. Cell 104, 531-543. (Pubitemid 32201948)
82. Stumvoll, M., Goldstein, B.J., and van Haeften, T.W. (2005). Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365, 1333-1346.
83. Summers, S.A. (2010). Sphingolipids and insulin resistance: the five Ws. Curr. Opin. Lipidol. 21, 128-135.
84. Swinburn, B.A., Sacks, G., Hall, K.D., McPherson, K., Finegood, D.T., Moodie, M.L., and Gortmaker, S.L. (2011). The global obesity pandemic: shaped by global drivers and local environments. Lancet 378, 804-814.
85. Tam, C.S., Lecoultre, V., and Ravussin, E. (2011). Novel strategy for the use of leptin for obesity therapy. Expert Opin. Biol. Ther. 11, 1677-1685.
86. Taniguchi, C.M., Emanuelli, B., and Kahn, C.R. (2006). Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 7, 85-96. (Pubitemid 43278292)
87. Torti, F.M., Dieckmann, B., Beutler, B., Cerami, A., and Ringold, G.M. (1985). A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia. Science 229, 867-869. (Pubitemid 16246586)
88. Um, S.H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P.R., Kozma, S.C., Auwerx, J., and Thomas, G. (2004). Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431, 200-205. (Pubitemid 39243474)
89. Vandanmagsar, B., Youm, Y.H., Ravussin, A., Galgani, J.E., Stadler, K., Mynatt, R.L., Ravussin, E., Stephens, J.M., and Dixit, V.D. (2011). The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17, 179-188.
90. Wan, M., Easton, R.M., Gleason, C.E., Monks, B.R., Ueki, K., Kahn, C.R., and Birnbaum, M.J. (2011a). Loss of Akt1 in mice increases energy expenditure and protects against diet-induced obesity. Mol. Cell. Biol. 32, 96-106.
91. Wan, M., Leavens, K.F., Saleh, D., Easton, R.M., Guertin, D.A., Peterson, T.R., Kaestner, K.H., Sabatini, D.M., and Birnbaum, M.J. (2011b). Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c. Cell Metab. 14, 516-527.
92. Wang, T.J., Larson, M.G., Vasan, R.S., Cheng, S., Rhee, E.P., McCabe, E., Lewis, G.D., Fox, C.S., Jacques, P.F., Fernandez, C., et al. (2011a). Metabolite profiles and the risk of developing diabetes. Nat. Med. 17, 448-453.
93. Wang, Y.C., McPherson, K., Marsh, T., Gortmaker, S.L., and Brown, M. (2011b). Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 378, 815-825.
94. Weisberg, S.P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R.L., and Ferrante, A.W., Jr. (2006). CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116, 115-124. (Pubitemid 43121796)
95. Wellen, K.E., Fucho, R., Gregor, M.F., Furuhashi, M., Morgan, C., Lindstad, T., Vaillancourt, E., Gorgun, C.Z., Saatcioglu, F., and Hotamisligil, G.S. (2007). Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis. Cell 129, 537-548. (Pubitemid 46660973)
96. Winer, S., Chan, Y., Paltser, G., Truong, D., Tsui, H., Bahrami, J., Dorfman, R., Wang, Y., Zielenski, J., Mastronardi, F., et al. (2009). Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 15, 921-929.
97. Winer, D.A., Winer, S., Shen, L., Wadia, P.P., Yantha, J., Paltser, G., Tsui, H., Wu, P., Davidson, M.G., Alonso, M.N., et al. (2011). B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med. 17, 610-617.
98. Yang, W.S., Lee, W.J., Huang, K.C., Lee, K.C., Chao, C.L., Chen, C.L., Tai, T.Y., and Chuang, L.M. (2003). mRNA levels of the insulin-signaling molecule SORBS1 in the adipose depots of nondiabetic women. Obes. Res. 11, 586-590.
99. Yip, S.C., Saha, S., and Chernoff, J. (2010). PTP1B: a double agent in metabolism and oncogenesis. Trends Biochem. Sci. 35, 442-449.
100. Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001). Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174. (Pubitemid 32995375)
101. Zick, Y. (2005). Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance. Sci. STKE 2005, pe4.